Literature DB >> 8535651

Long-term outcomes in rheumatoid arthritis.

T Pincus1.   

Abstract

Long-term outcomes in the majority of patients with established rheumatoid arthritis (RA) include radiographic progression, severe functional declines, work disability and premature mortality. These outcomes have been recognized primarily in long-term clinical observational studies, which also indicate that most courses of traditional therapies are discontinued within 2 yr. Severe long-term outcomes in RA are predicted more effectively by sustained inflammatory activity than by any measure of baseline activity at a single point in time. Aggressive efforts to control inflammatory activity prior to irreversible damage would appear to be a reasonable strategy for treatment of RA.

Entities:  

Mesh:

Year:  1995        PMID: 8535651

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  23 in total

Review 1.  Leflunomide: a review of its use in active rheumatoid arthritis.

Authors:  A Prakash; B Jarvis
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Early treatment of rheumatoid arthritis: rationale, evidence, and implications.

Authors:  L B van de Putte; A M van Gestel; P L van Riel
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

3.  Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.

Authors:  Thurayya Arayssi; Manale Harfouche; Andrea Darzi; Samar Al Emadi; Khalid A Alnaqbi; Humeira Badsha; Farida Al Balushi; Carole Dib; Bassel Elzorkany; Hussein Halabi; Mohammed Hammoudeh; Wissam Hazer; Basel Masri; Mira Merashli; Mohammed Omair; Nelly Salloum; Imad Uthman; Sumeja Zahirovic; Nelly Ziade; Raveendhara R Bannuru; Timothy McAlindon; Mohamed A Nomier; Jasvinder A Singh; Robin Christensen; Peter Tugwell; Holger Schünemann; Elie A Akl
Journal:  Clin Rheumatol       Date:  2018-08-10       Impact factor: 2.980

4.  Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients.

Authors:  A Boonen; A Chorus; H Miedema; D van der Heijde; H van der Tempel; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

5.  IL-1RA gene-transfected bone marrow-derived mesenchymal stem cells in APA microcapsules could alleviate rheumatoid arthritis.

Authors:  Jianhua Hu; Hongjian Li; Guanhao Chi; Zhao Yang; Yi Zhao; Wei Liu; Chao Zhang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

6.  Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease.

Authors:  S M Jones; C P Harris; J Lloyd; C A Stirling; J P Reckless; N J McHugh
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

7.  Reduction of interleukin-6 expression in human synoviocytes and rheumatoid arthritis rat joints by linear polarized near infrared light (Superlizer) irradiation.

Authors:  Hidefumi Araki; Asayo Imaoka; Noboru Kuboyama; Yoshimitsu Abiko
Journal:  Laser Ther       Date:  2011

8.  Contribution of the bone and cartilage/soft tissue components of the joint damage to the level of disability in rheumatoid arthritis patients: a longitudinal study.

Authors:  Lydia Abasolo; Jose Ivorra-Cortes; Leticia Leon; Juan A Jover; Benjamín Fernández-Gutiérrez; Luis Rodriguez-Rodriguez
Journal:  Clin Rheumatol       Date:  2018-10-16       Impact factor: 2.980

9.  Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients.

Authors:  H Bacquet-Deschryver; F Jouen; M Quillard; J F Ménard; V Goëb; T Lequerré; O Mejjad; A Daragon; F Tron; X Le Loët; O Vittecoq
Journal:  J Clin Immunol       Date:  2008-06-28       Impact factor: 8.317

10.  Reduction of monocyte chemoattractant protein-1 expression in rheumatoid arthritis rat joints with light-emitting diode phototherapy.

Authors:  Noboru Kuboyama; Yoshimitsu Abiko
Journal:  Laser Ther       Date:  2012-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.